Evidence map›Paper›PMID 25996154›Full record

ArticlePLoS pathogens2015

Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis.

Catherine W M Ong, Paul T Elkington, Sara Brilha, Cesar Ugarte-Gil, Maite T Tome-Esteban, Liku B Tezera, Przemyslaw J Pabisiak, Rachel C Moores, Tarangini Sathyamoorthy, Vimal Patel and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed, 225 citations in OpenAlex.

  1. Trial
  2. Doxycycline host-directed therapy in human pulmonary tuberculosis.The Journal of clinical investigation · 2021
    Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Towards host-directed therapy: The role of matrix metalloproteinases in the immunopathogenesis of tuberculosis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 4 countries.

Catherine W M OngInfectious Diseases and Immunity, Hammersmith Campus, Imperial College London, London, United Kingdom; Division of Infectious Diseases, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Paul T ElkingtonInfectious Diseases and Immunity, Hammersmith Campus, Imperial College London, London, United Kingdom; National Institute of Health Research (NIHR) Respiratory Biomedical Research Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Sara BrilhaInfectious Diseases and Immunity, Hammersmith Campus, Imperial College London, London, United Kingdom.
Cesar Ugarte-GilInfectious Diseases and Immunity, Hammersmith Campus, Imperial College London, London, United Kingdom; Instituto de Medicina Tropical Alexander Von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Maite T Tome-EstebanThe Heart Hospital, University College London Hospitals, London, United Kingdom.
Liku B TezeraInfectious Diseases and Immunity, Hammersmith Campus, Imperial College London, London, United Kingdom; National Institute of Health Research (NIHR) Respiratory Biomedical Research Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Przemyslaw J PabisiakInfectious Diseases and Immunity, Hammersmith Campus, Imperial College London, London, United Kingdom.
Rachel C MooresInfectious Diseases and Immunity, Hammersmith Campus, Imperial College London, London, United Kingdom.
Tarangini SathyamoorthyInfectious Diseases and Immunity, Hammersmith Campus, Imperial College London, London, United Kingdom.
Vimal PatelThe Heart Hospital, University College London Hospitals, London, United Kingdom.
Robert H GilmanDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America; Asociación Benéfica Proyectos en Informatica, Salud, Medicina, y Agricultura (PRISMA), Universidad Peruana Cayetano Heredia, Lima, Peru.
Joanna C PorterCentre for Inflammation and Tissue Repair, Department of Medicine, University College London, London, United Kingdom.
Jon S FriedlandInfectious Diseases and Immunity, Hammersmith Campus, Imperial College London, London, United Kingdom.
Imperial College London · GBUniversidad Peruana Cayetano Heredia · PENational University of Singapore · SGNIHR Southampton Respiratory Biomedical Research Unit · GBRoyal London Hospital · GBUniversity College Hospital at Westmoreland Street · GBUniversity College London · GBUniversity of Southampton · GB

Funding

Medical Research Council MR/K004158/1Medical Research Council MR/K007467/1Wellcome Trust
6 · The paper itself

Abstract

Pulmonary cavities, the hallmark of tuberculosis (TB), are characterized by high mycobacterial load and perpetuate the spread of M. tuberculosis. The mechanism of matrix destruction resulting in cavitation is not well defined. Neutrophils are emerging as key mediators of TB immunopathology and their influx are associated with poor outcomes. We investigated neutrophil-dependent mechanisms involved in TB-associated matrix destruction using a cellular model, a cohort of 108 patients, and in separate patient lung biopsies. Neutrophil-derived NF-kB-dependent matrix metalloproteinase-8 (MMP-8) secretion was up-regulated in TB and caused matrix destruction both in vitro and in respiratory samples of TB patients. Collagen destruction induced by TB infection was abolished by doxycycline, a licensed MMP inhibitor. Neutrophil extracellular traps (NETs) contain MMP-8 and are increased in samples from TB patients. Neutrophils lined the circumference of human pulmonary TB cavities and sputum MMP-8 concentrations reflected TB radiological and clinical disease severity. AMPK, a central regulator of catabolism, drove neutrophil MMP-8 secretion and neutrophils from AMPK-deficient patients secrete lower MMP-8 concentrations. AMPK-expressing neutrophils are present in human TB lung biopsies with phospho-AMPK detected in nuclei. These data demonstrate that neutrophil-derived MMP-8 has a key role in the immunopathology of TB and is a potential target for host-directed therapy in this infectious disease.

Indexed as

Host-Pathogen InteractionsActive Transport, Cell NucleusAdultAMP-Activated Protein KinasesCells, CulturedCohort StudiesEnzyme InhibitorsExtracellular Matrix ProteinsHumansImmunity, InnateLungMatrix Metalloproteinase 8Mycobacterium tuberculosisNeutrophil InfiltrationNeutrophilsNF-kappa BAMP-Activated Protein KinasesEnzyme InhibitorsExtracellular Matrix ProteinsMatrix Metalloproteinase 8MMP8 protein, humanNF-kappa B

Identifiers

PMID25996154
PMCPMC4440706
OpenAlexW264334781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.